| 22/10 | PHARMING N : Pharming Group Notice of 9M Results |  |
| 22/10 | PHARMING N : Group Notice of 9M Results | |
| 14/10 | JPMorgan opens South Korea commercial banking office in international expansion | |
| 14/09 | PHARMING N : Pharming announces results from clinical trials for the treatment of COVID-19.. | |
| 14/09 | PHARMING N : announces results from clinical trials for the treatment of COVID-19 with RUC.. | |
| 14/09 | Pharming Announces Results from Clinical Trials for the Treatment of COVID-19 with RUCO.. | |
| 05/08 | Pharming to Seek Acquisitions | |
| 05/08 | PHARMING N : Group reports financial results for the first half of 2021 | |
| 29/07 | SIGN UP NOW : Pharming's Half Year Financial Results Webinar | |
| 20/07 | PHARMING N : signs agreement with NewBridge Pharmaceuticals for the commercialization of R.. | |
| 20/07 | Pharming Signs Agreement with Newbridge Pharmaceuticals for the Commercialization of Ru.. | |
| 01/07 | ORCHARD THERAPEUTICS : to Collaborate With Pharming Group on Treatment for Hereditary Angi.. | |
| 01/07 | PHARMING N : Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and.. | |
| 01/07 | ORCHARD THERAPEUTICS : and Pharming Group Announce Collaboration to Develop and Commercial.. | |
| 01/07 | Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercia.. | |
| 01/07 | Orchard Therapeutics plc announced that it expects to receive $7.5 million in funding f.. | |
| 23/06 | PHARMING N : Pharming announces completion of enrolment in Phase II/III study with lenioli.. | |
| 23/06 | PHARMING N : announces completion of enrolment in Phase II/III study with leniolisib for a.. | |
| 23/06 | Pharming Group N.V Announces Completion of Enrolment in Phase II/III Study with Lenioli.. | |
| 21/06 | PHARMING GROUP N.V.(ENXTAM : PHARM) added to Netherlands ASCX AMS Small Cap Index | |
| 18/06 | PHARMING N : appoints Anurag Relan as Chief Medical Officer and Robert Friesen as Chief Sc.. | |
| 18/06 | Pharming Group N.V. Announces Executive Changes | |
| 18/06 | PHARMING GROUP N.V.(ENXTAM : PHARM) dropped from AMX Index | |
| 04/06 | PHARMING N : announces the reimbursement of RUCONEST® in Spain | |
| 01/06 | PHARMING N : Group to present at Jefferies Virtual Healthcare Conference | |
| 19/05 | Pharming Group N.V. Announces Executive Changes | |
| 13/05 | Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2021 | |
| 13/05 | PHARMING N : Group reports financial results for the first quarter of 2021 | |
| 13/05 | PHARMING GROUP N.V. : des résultats sans saveur |  |
| 22/04 | Pharming Group N.V Announces Enrolment of First Patient in Multicentre Phase IIb Clinic.. | |
| 23/03 | Pharming Group N.V. Announces Board Changes | |
| 08/03 | PHARMING N : Phishing, Pharming, Malware, And Other Internet Delights | |
| 04/03 | Pharming Group Seeks Acquisitions | |
| 04/03 | Pharming Group N.V. Reports Earnings Results for the Full Year Ended December 31, 2020 | |
| 04/03 | Pharming Group N.V. Provides Earnings Guidance for the Remainder of 2021 | |
| 02/03 | PHARMING N : Group, in collaboration with Invitae Corporation, launches genetic testing pr.. | |
| 02/03 | Pharming Group N.V. in Collaboration with Invitae Corporation, Launches Genetic Testing.. | |
| 2020 | PHARMING GROUP N.V.(NASDAQGM : PHAR) added to NASDAQ Composite Index | |
| 2020 | PHARMING N : Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR.. | |
| 2020 | PHARMING N : Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq List.. | |
| 2020 | PHARMING N : Reports on Extraordinary General Meeting of Shareholders | |
| 2020 | Pharming Group N.V. Announces Board Appointments | |
| 2020 | PHARMING N : announces enrolment of first patient in US clinical trial for the treatment o.. | |
| 2020 | Pharming Group N.V. Announces Enrolment of First Patient in US Clinical Trial for the T.. | |
| 2020 | PHARMING N : Juergen Ernst to retire from Pharming's Board of Supervisory Directors after .. | |
| 2020 | Pharming Group N.V. Announces Management Changes | |
| 2020 | PHARMING N : announces commitment to build a new downstream manufacturing facility for RUC.. | |
| 2020 | Pharming Group N.V. Announces Commitment to Build A New Downstream Manufacturing Facili.. | |
| 2020 | PHARMING N : appoints Jeroen Wakkerman as Chief Financial Officer | |
| 2020 | Pharming Group N.V. Appoints Jeroen Wakkerman as Chief Financial Officer, Effective 16 .. | |
| 2020 | PHARMING N : Group reports financial results for the first nine months of 2020 | |
| 2020 | PHARMING N : convenes Extraordinary General Meeting of shareholders | |
| 2020 | Pharming Group N.V. Provides Earnings Guidance for the Remainder of 2020 | |
| 2020 | Pharming Group N.V. Reports Earnings Results for the Nine Months Ended September 30, 20.. | |
| 2020 | PHARMING N : receives Orphan Drug Designation from the European Commission for leniolisib .. | |
| 2020 | Pharming Receives Orphan Drug Designation from the European Commission for Leniolisib f.. | |
| 2020 | PHARMING N : announces the publication of data from a compassionate use programme of RUCON.. | |
| 2020 | Pharming Announces the Publication of Data from a Compassionate Use Programme of RUCONE.. | |
| 2020 | PHARMING N : announces enrolment of first patient in multinational clinical trial for the .. | |
| 2020 | Pharming Group N.V. Announces Enrolment of First Patient in Multinational Clinical Tria.. | |
| 2020 | ORIGINAL-RESEARCH : Pharming Group NV (von First Berlin Equity Research GmbH):... |  |
| 2020 | PHARMING N : Group reports financial results for the first half of 2020 | |
| 2020 | Pharming Group N.V. Provides Earnings Guidance for the Remainder of 2020 | |
| 2020 | Pharming Group N.V. Reports Earnings Results for the Half Year Ended June 30, 2020 | |
| 2020 | Pharming Group Announces the Nomination of Barbara Yanni and Mark Pykett to the Board o.. | |
| 2020 | ORIGINAL-RESEARCH : Pharming Group NV (von First Berlin Equity Research GmbH):... | |
| 2020 | Pharming Group N.V. Provides Sales Guidance for the Remainder of 2020 | |
| 2020 | Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2020 | |
| 2020 | Pharming Group Receives European Commission Approval for Treatment of Acute Hereditary .. | |
| 2020 | ORIGINAL-RESEARCH : Pharming Group NV (von First Berlin Equity Research GmbH):... | |
| 2020 | PHARMING N : Seven Ways to Rob You during COVID-19 | |
| 2020 | PHARMING GROUP N.V. : bondit sur des résultats précoces avec Ruconest sur des patients tou.. | |
| 2020 | PHARMING N : reports encouraging results from use of RUCONEST® in COVID-19 patients | |
| 2020 | Pharming Group N.V. Reports Encouraging Results From Use of RUCONEST® in COVID-19 Patie.. | |
| 2020 | PHARMING N : Group convenes Annual General Meeting of shareholders | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
